These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33450404)

  • 21. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.
    Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X
    Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational Vaccine Design in the Time of COVID-19.
    Burton DR; Walker LM
    Cell Host Microbe; 2020 May; 27(5):695-698. PubMed ID: 32407707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate.
    Garassino MC; Vyas M; de Vries EGE; Kanesvaran R; Giuliani R; Peters S;
    Ann Oncol; 2021 May; 32(5):579-581. PubMed ID: 33582237
    [No Abstract]   [Full Text] [Related]  

  • 24. SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants.
    Moore JP; Offit PA
    JAMA; 2021 Mar; 325(9):821-822. PubMed ID: 33507218
    [No Abstract]   [Full Text] [Related]  

  • 25. Coronavirus vaccines get a biotech boost.
    Dance A
    Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847
    [No Abstract]   [Full Text] [Related]  

  • 26. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'I've never worked harder': the race to develop a COVID-19 vaccine.
    Woolston C
    Nature; 2020 Nov; 587(7833):322. PubMed ID: 33168971
    [No Abstract]   [Full Text] [Related]  

  • 28. [Not Available].
    Kokkinakis I
    Rev Med Suisse; 2021 Aug; 17(746):1379. PubMed ID: 34397187
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of vaccines for SARS-CoV-2.
    Ng WH; Liu X; Mahalingam S
    F1000Res; 2020; 9():. PubMed ID: 32850116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 shot protects monkeys.
    Cohen J
    Science; 2020 May; 368(6490):456-457. PubMed ID: 32355008
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunological research of COVID-19 and emerging infectious diseases].
    Cao XT
    Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(1):1-6. PubMed ID: 33423443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 vaccines are not free of neurological side effects.
    Finsterer J; Scorza FA
    Acta Neurol Scand; 2021 Jul; 144(1):109-110. PubMed ID: 34002379
    [No Abstract]   [Full Text] [Related]  

  • 33. Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey.
    Barrière J; Gal J; Hoch B; Cassuto O; Leysalle A; Chamorey E; Borchiellini D
    Ann Oncol; 2021 May; 32(5):673-674. PubMed ID: 33529740
    [No Abstract]   [Full Text] [Related]  

  • 34. COVID-19 vaccines-The way forward.
    Klimek L; Agache I; Cooke E; Jutel M; Akdis CA; O'Hehir R
    Allergy; 2022 Jan; 77(1):15-16. PubMed ID: 34191300
    [No Abstract]   [Full Text] [Related]  

  • 35. Understanding the determinants of acceptance of COVID-19 vaccines: a challenge in a fast-moving situation.
    Verger P; Peretti-Watel P
    Lancet Public Health; 2021 Apr; 6(4):e195-e196. PubMed ID: 33556329
    [No Abstract]   [Full Text] [Related]  

  • 36. Adapting Cancer Civil Society Organizations to Accelerate COVID-19 Vaccinations in People Living With Cancer in Low- and Middle-Income Countries-A Commentary.
    Munisamy M; Ndoh K; Abdelbadee A; Espejo I; Manjuh F; Tamas A; Salako O; Roitberg F
    JCO Glob Oncol; 2021 Jul; 7():1194-1198. PubMed ID: 34292779
    [No Abstract]   [Full Text] [Related]  

  • 37. COVID-19, cults, and the anti-vax movement.
    Mylan S; Hardman C
    Lancet; 2021 Mar; 397(10280):1181. PubMed ID: 33773626
    [No Abstract]   [Full Text] [Related]  

  • 38. [Not Available].
    Chávez-García LC; Juárez-León O; Barreda-Mecalco E; Baeza-Zapata A; García-Juárez I
    Salud Publica Mex; 2021 Sep; 63(5):588. PubMed ID: 35099877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies.
    Greenberger LM; Saltzman LA; Senefeld JW; Johnson PW; DeGennaro LJ; Nichols GL
    Cancer Cell; 2021 Aug; 39(8):1031-1033. PubMed ID: 34331856
    [No Abstract]   [Full Text] [Related]  

  • 40. COVID-19 vaccination in pediatric cancer patients: A high priority.
    Charla Y; Kalra M; Chopra N; Choudhury S
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29397. PubMed ID: 34636133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.